Detection of tissue-specific effects by methotrexate on differentiating mouse embryonic stem cells

Area of Science:

• Developmental toxicology
• Stem cell biology
• Pharmacology

Background:

• Pluripotent embryonic stem (ES) cells enable in vitro monitoring of cell differentiation.
• This study identifies marker genes for murine ES cell differentiation.
• The goal is to predict chemical effects on specific target tissues.

Purpose of the Study:

• To identify marker genes for cardiomyocyte and osteoblast differentiation in vitro.
• To assess the potential of murine ES cells to predict chemical effects on cell differentiation.
• To evaluate methotrexate's teratogenic effects on specific cell lineages in vitro.

Main Methods:

• Murine ES cells were differentiated in vitro into cardiomyocytes and osteoblasts.
• Gene expression of key markers (Oct-4, Brachyury, Nkx2.5, alpha myosin heavy chain, Cbfa1, Osteocalcin) was analyzed.
• Differentiating ES cells were exposed to methotrexate at non-cytotoxic concentrations.

Main Results:

• Methotrexate exposure did not alter cardiomyocyte-specific gene expression.
• Osteoblast-specific genes Cbfa1 and Osteocalcin showed decreased expression (30% and 60% respectively).
• Early markers for undifferentiated and mesodermal cells remained unchanged.

Conclusions:

• In vitro differentiation of ES cells can reveal target cell specificity of chemical teratogens.
• This approach supports the integration of in vitro tests into developmental toxicity assessment strategies.
• Methotrexate demonstrated specific toxicity towards osteoblast differentiation in this model.